Phase I Experimental Therapeutics Program Director
Children's Mercy - Kansas City Cancer Center (CMCC)
The Division of Hematology/Oncology/BMT (H/O/BMT) is seeking a board certified and Phase I experienced Pediatric Hematologist/Oncologist to be Program Director of its Phase I Experimental Therapeutics (ET) program in the Children's Mercy - Kansas City Cancer Center (CMCC). The ET Program Director also serves as a member of the hospital's Clinical Pharmacology program, as well as Co-Director of the Drug Discovery and Delivery Experimental Therapeutics (D3ET) program of the NCI-designated University of Kansas Cancer Center (KUCC). The D3ET Co-Director, working closely with the KU School of Pharmacy's drug discovery and medicinal chemistry programs with its compound libraries and high throughput screening capability, guides the research for both adult and pediatric drug discovery. CMCC, as a consortium partner in the NCI-designated KUCC, enables our faculty to have active laboratory and clinical research trials in both the KUCC and CMCC labs and CTSU, including the CMH ET program's current clinical and lab research in drug discovery, repurposing, and tumor modeling. The program director will be joined with 3 Pediatric H/O BC physicians currently active in the ET program, a dedicated nurse practitioner, 4 research associates, and in division regulatory affairs associates. The entire H/O/BMT faculty is comprised of 29 physicians and 32 nurse practitioners. The CMCC with strong philanthropic and grant support couples the Phase I program with its internal core facilities and research in constitutional and cancer genomics, cellular therapy, stem cell transplant, and population sciences. Further synergism with the CMCC tumor and population specific programs is facilitated by a dedicated Cancer programs and research administrator. The CMCC sees 200 newly diagnosed childhood cancer patients annually plus regional high risk and recurrent referred patients within a dedicated 38 bed fully hepafiltered inpatient unit and a large 18 exam room 14 infusion bay dedicated H/O clinic. The CMCC is a multispecialty program with pediatric medical, surgical, radiology, pathology, and radiation specialists embedded within each program team allowing for close clinical and research collaborations. CMCC is a full member of the Children's Oncology Group and CMCC members are fully supported and encouraged to participate in this and other consortia. CMCC is an American College of Surgeon's Commission on Cancer accredited as well as a FACT-accredited institution.
Children’s Mercy is one of the nations’ top pediatric medical centers. The 354-bed hospital provides care for children from birth through the age of 21 and has been ranked by U.S. News & World Report as one of “America’s Best Children’s Hospitals.” It has achieved Magnet nursing designation 3 consecutive terms, an honor awarded to fewer than seven percent of all hospitals nationally. The faculty of 600 pediatricians and researchers across more than 40 subspecialties are actively involved in clinical care, pediatric research, and educating the next generation of pediatric subspecialists. There are more than 20 fellowship programs within the departments of pediatrics, surgery, radiology, dentistry, anesthesiology, and pathology. Children’s Mercy is also affiliated with the University of Missouri-Kansas City School of Medicine and is currently working with the University of Kansas Hospital to develop an integrated pediatric department.
Kansas City is located in the heart of America. It has small-town friendliness but big-city dining, a variety of entertainment options, incredible jazz, professional sports, world-renowned museums, great shopping and more fountains than any city in the world besides Rome. The city, a metropolitan area of more than 2 million people, has some of the best public school districts in the nation.
Children’s Mercy Kansas City is an independent, non-profit, 354-bed pediatric health system, serving half a million
patients each year from across the country. Children’s Mercy is ranked by U.S. News & World Report as one of “America’s Best Children’s Hospitals” and has received Magnet® recognition three times for excellence in nursing services. In affiliation with the University of Missouri-Kan...sas City, our faculty of nearly 700 pediatric subspecialists and researchers is actively involved in clinical care, pediatric research and educating the next generation of pediatric subspecialists. And, our leadership in pediatric genomic medicine and clinical pharmacology is driving research and innovation in heart care, neonatology, cancer treatment and other subspecialties to transform outcomes for children here and around the world. For more information about Children’s Mercy Kansas City, and about Kansas City itself,